Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study

Authors: Tolley, Elisabeth Reuben ^{1, 2}, Nielsen, Torsten Holm ^{1, 3, 4}, Hersby, Ditte Stampe ¹, Østergaard, Simon ^{3, 5}, Rasmussen, Malin ⁶, Clausen, Michael Roost ⁷, Al-Mashhadi, Ahmed Ludvigsen ⁸, Egeberg, Karina Moeslund ⁹, Haunstrup, Laura Mors ¹⁰, Brieghel, Christian ¹, Niemann, Carsten Utoft ^{1, 2}, El-Galaly, Tarec Christoffer ^{6, 10}, Pedersen, Lars Møller ^{2, 3, ∗}

Source: In Blood Advances 25 February 2025 9(4):893-905

Sexual health and testosterone concentration in male lymphoma survivors: A systematic review

Authors: Micas Pedersen, Signe ^{a, g, ⁎}, Hersby, Ditte Stampe ^a, Jarden, Mary ^{a, c}, Nielsen, Torsten Holm ^{a, b}, Gang, Anne Ortved ^{a, c}, Poulsen, Christian Bjørn ^d, de Nully Brown, Peter ^a, Jørgensen, Niels ^e, Feltoft, Claus Larsen ^f, Pedersen, Lars Møller ^{c, d}

Source: In Heliyon 15 June 2024 10(11)

Next generation sequencing in routine diagnostics of mature non‐Hodgkin's B‐cell lymphomas

Authors: Breinholt, Marie Fredslund, Schejbel, Lone, Gang, Anne Ortved, Nielsen, Torsten Holm, Pedersen, Lars Møller, Høgdall, Estrid, Nørgaard, Peter

Source: European journal of haematology. 111(4):583-591

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193005101.0x000001&indx=1&recIds=ETOCvdc_100193005101.0x000001

Multi-site pre-therapeutic biopsies demonstrate genetic heterogeneity in patients with newly diagnosed diffuse large B-cell lymphoma

Authors: Hersby, Ditte Stampe, Schejbel, Lone, Breinholt, Marie Fredslund, Høgdall, Estrid, Nørgaard, Peter, Dencker, Ditte, Nielsen, Torsten Holm, Pedersen, Lars Møller, Gang, Anne Ortved

Source: Leukemia & lymphoma. 64(9):1527-1535

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191127721.0x000001&indx=1&recIds=ETOCvdc_100191127721.0x000001

Inactivating BTK mutations in large B‐cell lymphoma in a real‐world cohort: Strong correlation with BCL2 translocation

Authors: Schejbel, Lone, Breinholt, Marie Fredslund, Gang, Anne Ortved, Nielsen, Torsten Holm, Pedersen, Lars Møller, Høgdall, Estrid, Nørgaard, Peter

Source: EJHaem. 3(3):936-939

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182035237.0x000001&indx=1&recIds=ETOCvdc_100182035237.0x000001

Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies.

Authors: Hersby, Ditte Stampe, Schejbel, Lone, Breinholt, Marie Fredslund, Høgdall, Estrid, Nørgaard, Peter, Nielsen, Torsten Holm, Pedersen, Lars Møller, Gang, Anne Ortved

Source: Annals of Hematology; Dec2024, Vol. 103 Issue 12, p5835-5848, 14p

Subject Terms: NUCLEOTIDE sequencing, MEDICAL sciences, LIFE sciences, GENETICS, CUSTOM design

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study.

Authors: Østergaard, Simon, Munksgaard, Lars, Nielsen, Torsten Holm, Hammer, Troels, Pedersen, Lars Møller, Ølgod Pedersen, Mette, Gjerdrum, Lise Mette Rahbek

Source: EJHaem; Dec2024, Vol. 5 Issue 6, p1269-1273, 5p

Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.

Authors: Østergaard, Simon, Schejbel, Lone, Breinholt, Marie Fredslund, Pedersen, Mette Ølgod, Hammer, Troels, Munksgaard, Lars, Nørgaard, Peter, Høgdall, Estrid, Gjerdrum, Lise Mette Rahbek, Nielsen, Torsten Holm

Source: Leukemia & Lymphoma; Jun2024, Vol. 65 Issue 6, p758-767, 10p

Subject Terms: NUCLEOTIDE sequencing, SOMATIC mutation, LYMPHOMAS, PHENOTYPES, GENETIC mutation, WALDENSTROM'S macroglobulinemia

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

Authors: Assouline, Sarit E., Nielsen, Torsten Holm ^*, Yu, Stephen ^*, Alcaide, Miguel, Chong, Lauren, MacDonald, David, Tosikyan, Axel, Kukreti, Vishal, Kezouh, Abbas, Petrogiannis-Haliotis, Tina, Albuquerque, Marco, Fornika, Daniel, Alamouti, Sepideh, Froment, Remi, Greenwood, Celia M.T., Oros, Kathleen Klein, Camglioglu, Errol, Sharma, Ayushi, Christodoulopoulos, Rosa, Rousseau, Caroline, Johnson, Nathalie, Crump, Michael, Morin, Ryan D., Mann, Koren K.

Source: In Blood 14 July 2016 128(2):185-194

Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency.

Authors: Micas Pedersen, Signe, Feltoft, Claus Larsen, Nielsen, Torsten Holm, de Nully Brown, Peter, Gang, Anne Ortved, Pedersen, Lars Møller, Jørgensen, Niels

Source: Annals of Hematology; Jan2024, Vol. 103 Issue 1, p227-239, 13p

Subject Terms: HODGKIN'S disease, TESTOSTERONE

Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma.

Authors: Pedersen, Signe Micas, Nielsen, Torsten Holm, Gang, Anne Ortved, Poulsen, Christian Bjørn, Brown, Peter de Nully, Jørgensen, Niels, Feltoft, Claus Larsen, Pedersen, Lars Møller

Source: Sexual Medicine; Apr2023, Vol. 11 Issue 2, p1-10, 10p

Subject Terms: SEXUAL dysfunction, B cell lymphoma, LYMPHOMAS, HODGKIN'S disease, SEXUAL health

systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer.

Authors: Lewinter, Christian, Nielsen, Torsten Holm, Edfors, Lars Robert, Linde, Cecilia, Bland, John Martin, LeWinter, M, Cleland, John G F, Køber, Lars, Braunschweig, Frieder, Mansson-Broberg, Agneta

Source: European Heart Journal; 7/14/2022, Vol. 43 Issue 27, p2562-2569, 8p

Subject Terms: LEFT ventricular dysfunction, ACE inhibitors, RENIN-angiotensin system, ANGIOTENSIN-receptor blockers, TRASTUZUMAB, ANTHRACYCLINES, ADRENERGIC beta blockers

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Abstract 10311: Atrioventricular Junctional Ablation in Patients With Atrial Fibrillation With and Without Heart Failure: A Meta-Analysis

Authors: Lewinter, Christian, Sögütlü, Eslem, Nielsen, Torsten Holm H, Cleland, John G, Kober, Lars, Lewinter, Martin M, Linde, cecilia M, Braunschweig, Frieder

Source: Circulation (Ovid); November 2022, Vol. 146 Issue: Supplement 1 pA10311-A10311, 1p

Targeting EVI1-Overexpressing AML with Darinaparsin

Authors: Mann, Koren K ^*, Johnson, Nathalie ^*, Nielsen, Torsten Holm ^*, Garnier, Nicolas ^*, Kwan, Stanley ^*, Cocolakis, Eftihia ^*, Hebert, Josee, Morgan, Robert ^*, Miller, Wilson H., Jr.

Source: In Blood 18 November 2011 118(21):4269-4269

TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real‐Word Patients With Primary Large B‐Cell Lymphoma.

Authors: Breinholt, Marie Fredslund^1,2 (AUTHOR) mariebreinholt@hotmail.com, Schejbel, Lone¹ (AUTHOR), Gang, Anne Ortved^2,3 (AUTHOR), Christensen, Ib Jarle¹ (AUTHOR), Nielsen, Torsten Holm^3,4,5 (AUTHOR), Pedersen, Lars Møller^2,5 (AUTHOR), Høgdall, Estrid^1,2 (AUTHOR), Nørgaard, Peter^1,6 (AUTHOR)

Source: European Journal of Haematology. Dec2024, p1. 7p. 2 Illustrations.

Subject Terms: *GENETIC mutation, *OVERALL survival, *MYELOID differentiation factor 88, *LYMPHOMAS, *BIOMARKERS

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.